- Home
- USNA vs CMPX Comparison
USNA vs CMPX Comparison
Compare USNA & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- CMPX
- Stock Information
- Founded
- USNA 1992
- CMPX 2014
- Country
- USNA United States
- CMPX United States
- Employees
- USNA N/A
- CMPX N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- USNA Health Care
- CMPX Health Care
- Exchange
- USNA Nasdaq
- CMPX Nasdaq
- Market Cap
- USNA 565.5M
- CMPX 576.5M
- IPO Year
- USNA 1996
- CMPX N/A
- Fundamental
- Price
- USNA $26.46
- CMPX $3.57
- Analyst Decision
- USNA Hold
- CMPX Strong Buy
- Analyst Count
- USNA 1
- CMPX 7
- Target Price
- USNA $36.00
- CMPX $14.71
- AVG Volume (30 Days)
- USNA 136.2K
- CMPX 1.7M
- Earning Date
- USNA 10-21-2025
- CMPX 11-11-2025
- Dividend Yield
- USNA N/A
- CMPX N/A
- EPS Growth
- USNA N/A
- CMPX N/A
- EPS
- USNA 1.80
- CMPX N/A
- Revenue
- USNA $899,221,000.00
- CMPX N/A
- Revenue This Year
- USNA $13.94
- CMPX N/A
- Revenue Next Year
- USNA $7.95
- CMPX N/A
- P/E Ratio
- USNA $14.84
- CMPX N/A
- Revenue Growth
- USNA 2.75
- CMPX N/A
- 52 Week Low
- USNA $23.10
- CMPX $1.27
- 52 Week High
- USNA $41.84
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- USNA 27.82
- CMPX 53.08
- Support Level
- USNA $26.88
- CMPX $3.31
- Resistance Level
- USNA $27.95
- CMPX $3.80
- Average True Range (ATR)
- USNA 0.74
- CMPX 0.24
- MACD
- USNA -0.27
- CMPX -0.02
- Stochastic Oscillator
- USNA 3.47
- CMPX 47.91
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.